In addition, the inflammatory response pathway was found to be enriched in MES samples as compared to MEL, accompanied by significantly high expression of CXCL1 and its receptor, CXCR2, as well as chemokine receptors CCR4 and CCR6, in melanomas characterised by the invasive gene signature. The gene discussed is CCR4; the disease is melanoma.